Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma

Описание к видео Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma

During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint satellite symposium entitled ‘Sequencing immune-based therapies in B-cell malignancies’.
Here, the Multiple Myeloma Hub is pleased to share the session, which covered how to sequence CAR T-cell therapy and bispecific antibodies in relapsed/refractory (R/R) multiple myeloma (MM), presented by Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, US.

This independent educational activity was supported by Bristol Myers Squibb. All content was developed independently by the faculty.

Комментарии

Информация по комментариям в разработке